CAS: 1818393-16-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | APG 115 REF: IN-DA01N14UCAS: 1818393-16-6 | 95% | To inquire | Tue 04 Mar 25 |
 | APG 115 REF: TR-A357705CAS: 1818393-16-6 | - - - | 11,848.00 € | Mon 14 Apr 25 |
 | APG 115 REF: 3D-TXC39316CAS: 1818393-16-6 | Min. 95% | To inquire | Tue 15 Apr 25 |
 | Alrizomadlin REF: TM-T14303CAS: 1818393-16-6 | 98.69% - 98.79% | 250.00 €~4,532.00 € | Tue 06 May 25 |
APG 115
CAS:1818393-16-6
Formula:
C34H38Cl2FN3O4
Purity:
95%
Color and Shape:
Solid
Molecular weight:
642.5876
Ref: IN-DA01N14U
| 1mg | 112.00 € | ||
| 5mg | 159.00 € | ||
| 10mg | 238.00 € | ||
| 25mg | 613.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 4 Mar 2025
APG 115
Controlled ProductCAS:1818393-16-6
Formula:
C34H38Cl2FN3O4
Color and Shape:
Neat
Molecular weight:
642.588
Ref: TR-A357705
| 250mg | 11,848.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
APG 115
CAS:1818393-16-6
APG 115 is a synthetic growth factor that has potent antitumor activity in animal models. …
Formula:
C34H38Cl2FN3O4
Purity:
Min. 95%
Molecular weight:
642.6 g/mol
Ref: 3D-TXC39316
| 5mg | 1,108.00 € | ||
| 10mg | 1,542.00 € | ||
| 25mg | 2,890.00 € | ||
| 50mg | 4,624.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
Alrizomadlin
CAS:1818393-16-6
Alrizomadlin is an orally active MDM2 inhibitor. APG-115 shows significant dose-dependent inhibitory effects on TP53wt …
Formula:
C34H38Cl2FN3O4
Purity:
98.69% - 98.79%
Color and Shape:
Solid
Molecular weight:
642.59
Ref: TM-T14303
| 1mg | 250.00 € | ||
| 5mg | 588.00 € | ||
| 10mg | 843.00 € | ||
| 25mg | 1,206.00 € | ||
| 50mg | 1,454.00 € | ||
| 100mg | 1,890.00 € | ||
| 1mL*10mM (DMSO) | 747.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
